174 related articles for article (PubMed ID: 28277121)
1. MAGE-A family serves as poor prognostic markers and potential therapeutic targets for epithelial ovarian cancer patients: a retrospective clinical study.
Sang M; Wu X; Fan X; Lian Y; Sang M
Gynecol Endocrinol; 2017 Jun; 33(6):480-484. PubMed ID: 28277121
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer.
Xu Y; Wang C; Zhang Y; Jia L; Huang J
Sci Rep; 2015 Jul; 5():12104. PubMed ID: 26175056
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
[TBL] [Abstract][Full Text] [Related]
4. MAGE-A family expression is correlated with poor survival of patients with lung adenocarcinoma: a retrospective clinical study based on tissue microarray.
Sang M; Gu L; Yin D; Liu F; Lian Y; Zhang X; Liu S; Huang W; Wu Y; Shan B
J Clin Pathol; 2017 Jun; 70(6):533-540. PubMed ID: 27864450
[TBL] [Abstract][Full Text] [Related]
5. High expression of KIF14 is associated with poor prognosis in patients with epithelial ovarian cancer.
Qiu HL; Deng SZ; Li C; Tian ZN; Song XQ; Yao GD; Geng JS
Eur Rev Med Pharmacol Sci; 2017 Jan; 21(2):239-245. PubMed ID: 28165566
[TBL] [Abstract][Full Text] [Related]
6. MAGE-A family is involved in gastric cancer progression and indicates poor prognosis of gastric cancer patients.
Lian Y; Sang M; Gu L; Liu F; Yin D; Liu S; Huang W; Wu Y; Shan B
Pathol Res Pract; 2017 Aug; 213(8):943-948. PubMed ID: 28647208
[TBL] [Abstract][Full Text] [Related]
7. Expression of TBC1D16 Is Associated with Favorable Prognosis of Epithelial Ovarian Cancer.
Yang Z; Shen H; He W; Ouyang L; Guo Y; Qian F; Xu B; Xie D; Yang G
Tohoku J Exp Med; 2018 Jul; 245(3):141-148. PubMed ID: 29962380
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of tumor necrosis factor receptor-associated protein 1 (TRAP1) are associated with poor prognosis of epithelial ovarian cancer.
Lv Q; Sun H; Cao C; Gao B; Qi Y
Tumour Biol; 2016 Feb; 37(2):2721-7. PubMed ID: 26408177
[TBL] [Abstract][Full Text] [Related]
9. Expression and immune responses to MAGE antigens predict survival in epithelial ovarian cancer.
Daudi S; Eng KH; Mhawech-Fauceglia P; Morrison C; Miliotto A; Beck A; Matsuzaki J; Tsuji T; Groman A; Gnjatic S; Spagnoli G; Lele S; Odunsi K
PLoS One; 2014; 9(8):e104099. PubMed ID: 25101620
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Serum Creatinine Levels in Patients with Epithelial Ovarian Cancer.
Lafleur J; Hefler-Frischmuth K; Grimm C; Schwameis R; Gensthaler L; Reiser E; Hefler LA
Anticancer Res; 2018 Sep; 38(9):5127-5130. PubMed ID: 30194159
[TBL] [Abstract][Full Text] [Related]
11. Expression of tumor antigens on primary ovarian cancer cells compared to established ovarian cancer cell lines.
Kloudová K; Hromádková H; Partlová S; Brtnický T; Rob L; Bartůňková J; Hensler M; Halaška MJ; Špíšek R; Fialová A
Oncotarget; 2016 Jul; 7(29):46120-46126. PubMed ID: 27323861
[TBL] [Abstract][Full Text] [Related]
12. Expression of Placenta Growth Factor Is Associated with Unfavorable Prognosis of Advanced-Stage Serous Ovarian Cancer.
Meng Q; Duan P; Li L; Miao Y
Tohoku J Exp Med; 2018 Apr; 244(4):291-296. PubMed ID: 29643276
[TBL] [Abstract][Full Text] [Related]
13. NEDD9 overexpression is associated with the progression of and an unfavorable prognosis in epithelial ovarian cancer.
Wang H; Mu X; Zhou S; Zhang J; Dai J; Tang L; Xiao L; Duan Z; Jia L; Chen S
Hum Pathol; 2014 Feb; 45(2):401-8. PubMed ID: 24439227
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer.
Masoumi-Moghaddam S; Amini A; Wei AQ; Robertson G; Morris DL
Oncotarget; 2015 Sep; 6(29):28491-501. PubMed ID: 26143638
[TBL] [Abstract][Full Text] [Related]
15. Low levels of ADAM23 expression in epithelial ovarian cancer are associated with poor survival.
Ma R; Tang Z; Sun K; Ye X; Cheng H; Chang X; Cui H
Pathol Res Pract; 2018 Aug; 214(8):1115-1122. PubMed ID: 29921495
[TBL] [Abstract][Full Text] [Related]
16. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.
Li T; Xue H; Guo Y; Guo K
Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Siah2 Is Associated With Poor Prognosis in Patients With Epithelial Ovarian Carcinoma.
Gao Y; Liu Y; Meng F; Shang P; Wang S; Zhang Y; Sun Y; Wang Y; Wang J; Chen X
Int J Gynecol Cancer; 2016 Jan; 26(1):114-9. PubMed ID: 26512788
[TBL] [Abstract][Full Text] [Related]
18. Prognostic importance of survivin, Ki-67, and topoisomerase IIα in ovarian carcinoma.
Kucukgoz Gulec U; Gumurdulu D; Guzel AB; Paydas S; Seydaoglu G; Acikalin A; Khatib G; Zeren H; Vardar MA; Altintas A
Arch Gynecol Obstet; 2014 Feb; 289(2):393-8. PubMed ID: 23974278
[TBL] [Abstract][Full Text] [Related]
19. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer.
Qiu JJ; Lin YY; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
Gynecol Oncol; 2014 Jul; 134(1):121-8. PubMed ID: 24662839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
